Investor Insights

This summary was created by AI, based on 1 opinions in the last 12 months.

Experts are speculating that Cytokinetics shares are on the rise due to rumors of a potential buyout by Novartis. One review suggests selling half of the holding to lock in profits while letting the rest run. Overall, the stock is experiencing a significant increase in value, and investors are advised to monitor the situation closely.

Consensus
Buy
Valuation
Fair Value
PARTIAL SELL
Cytokinetics

Shares have soared lately on rumours that Novartis will by them out. Sell half your holding and let the rest run.

biotechnology / pharmaceutical
Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Cytokinetics(CYTK-Q) Rating

Ranking : 3 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 1

Total Signals / Votes : 1

Stockchase rating for Cytokinetics is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Cytokinetics(CYTK-Q) Frequently Asked Questions

What is Cytokinetics stock symbol?

Cytokinetics is a American stock, trading under the symbol CYTK-Q on the NASDAQ (CYTK). It is usually referred to as NASDAQ:CYTK or CYTK-Q

Is Cytokinetics a buy or a sell?

In the last year, 1 stock analyst published opinions about CYTK-Q. 0 analysts recommended to BUY the stock. 1 analyst recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Cytokinetics.

Is Cytokinetics a good investment or a top pick?

Cytokinetics was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Cytokinetics.

Why is Cytokinetics stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Cytokinetics worth watching?

In the last year 1 stock analyst on Stockchase covered Cytokinetics. The stock is worth watching.

What is Cytokinetics stock price?

On 2024-02-29, Cytokinetics (CYTK-Q) stock closed at a price of $72.205.